• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米兰标准范围内行部分肝切除术治疗肝细胞癌的结果。

Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.

机构信息

Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, 102 Pok Fu Lam Road, Hong Kong, China.

出版信息

Br J Surg. 2011 Sep;98(9):1292-300. doi: 10.1002/bjs.7583. Epub 2011 Jun 7.

DOI:10.1002/bjs.7583
PMID:21656513
Abstract

BACKGROUND

There is a trend to offer liver transplantation to patients with hepatocellular carcinoma (HCC) with tumour status within the Milan criteria but with preserved liver function. This study aimed to evaluate the outcome of such patients following partial hepatectomy as primary treatment.

METHODS

A retrospective analysis was performed on all adult patients with HCC and tumour status within the Milan criteria undergoing partial hepatectomy at a single centre from 1995 to 2008. Their outcomes were compared with those of similar patients having right-lobe living donor liver transplantation (LDLT) as primary treatment.

RESULTS

A total of 408 patients with HCC were enrolled. Some 384 patients with a solitary tumour 5 cm or less in diameter had a better 5-year survival rate than 24 patients with oligonodular tumours (2-3 nodules, each 3 cm or less in size) (70·7 versus 46 per cent; P = 0·025). Multivariable analysis identified younger age (65 years or less), lack of postoperative complications, negative resection margin, absent microvascular invasion and non-cirrhotic liver as predictors of favourable overall survival. The 5-year survival rate of 287 younger patients with chronic liver disease and R0 hepatectomy was 72·8 per cent, comparable to that of 81 per cent in 50 similar patients treated by LDLT (P = 0·093).

CONCLUSION

Partial hepatectomy for patients with HCC and tumour status within the Milan criteria achieved a satisfactory 5-year survival rate, particularly in younger patients with solitary tumours and R0 hepatectomy. Patients with oligonodular tumours have a worse survival and might benefit from liver transplantation.

摘要

背景

目前存在一种趋势,倾向于为符合米兰标准的肝癌(HCC)患者提供肝移植治疗,这些患者的肿瘤状态在米兰标准内,但肝功能保留。本研究旨在评估这些患者行肝部分切除术作为初始治疗的结果。

方法

对 1995 年至 2008 年在单中心行肝部分切除术的所有符合米兰标准的 HCC 且肿瘤状态在米兰标准内的成年患者进行回顾性分析。将其结果与接受右半活体肝移植(LDLT)作为初始治疗的类似患者的结果进行比较。

结果

共纳入 408 例 HCC 患者。384 例单发肿瘤直径 5cm 或以下的患者 5 年生存率优于 24 例多结节肿瘤(2-3 个结节,每个结节直径 3cm 或以下)患者(70.7%比 46%;P=0.025)。多变量分析确定年龄(65 岁或以下)、无术后并发症、切缘阴性、无微血管侵犯和非肝硬化肝脏是总体生存良好的预测因素。287 例慢性肝病且 R0 肝切除的年轻患者 5 年生存率为 72.8%,与 50 例接受 LDLT 的类似患者的 81%相似(P=0.093)。

结论

对于符合米兰标准的 HCC 患者,肝部分切除术可获得令人满意的 5 年生存率,尤其是对于单发肿瘤和 R0 肝切除的年轻患者。多结节肿瘤患者的生存率较差,可能受益于肝移植。

相似文献

1
Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.米兰标准范围内行部分肝切除术治疗肝细胞癌的结果。
Br J Surg. 2011 Sep;98(9):1292-300. doi: 10.1002/bjs.7583. Epub 2011 Jun 7.
2
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.共存肝硬化对符合米兰标准的肝细胞癌患者肝部分切除术后结局的影响:293例患者分析
Surgery. 2007 Nov;142(5):685-94. doi: 10.1016/j.surg.2007.05.009.
3
Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.对于符合米兰标准的多发性结节Child-Pugh A级肝细胞癌患者,进行活体供肝肝移植或肝切除术。
Transpl Int. 2014 Jun;27(6):562-9. doi: 10.1111/tri.12297. Epub 2014 Apr 2.
4
Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.巨大肝细胞癌患者初次切除及复发病灶治疗后的结局
Br J Surg. 2007 Mar;94(3):320-6. doi: 10.1002/bjs.5622.
5
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.米兰标准以外的肝细胞癌的外科治疗。肝切除、挽救性移植和原位肝移植的结果。
Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.
6
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.肝细胞癌肝移植的生存结果,比较丙型肝炎与其他肝硬化病因的影响。
Liver Transpl. 2007 Jun;13(6):807-13. doi: 10.1002/lt.21054.
7
Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.符合米兰标准的肝细胞癌患者在活体肝移植前进行局部区域治疗的有效性。
Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067.
8
Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.肝硬化患者早期肝细胞癌肝切除的疗效:根据米兰标准进行亚组分析。
Jpn J Clin Oncol. 2007 Apr;37(4):287-95. doi: 10.1093/jjco/hym025.
9
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.米兰标准外肝癌患者行肝移植与部分肝切除术后结局的对比分析。
Am J Clin Oncol. 2011 Oct;34(5):466-71. doi: 10.1097/COC.0b013e3181ec63dd.
10
[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].[肝细胞癌:肝硬化对治疗和预后的意义——回顾性研究]
Ned Tijdschr Geneeskd. 2010;154:A1747.

引用本文的文献

1
Efficacy of Jiedu formula as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery: a propensity score matching study.解毒方作为肝细胞癌根治术后早期复发辅助治疗的疗效:一项倾向评分匹配研究
J Tradit Chin Med. 2025 Apr;45(2):443-449. doi: 10.19852/j.cnki.jtcm.2025.02.019.
2
Comprehensive pan-cancer investigation of carnosine dipeptidase 1 and its prospective prognostic significance in hepatocellular carcinoma.肌肽二肽酶1在全癌中的综合研究及其在肝细胞癌中的潜在预后意义。
Open Med (Wars). 2024 Jun 14;19(1):20240982. doi: 10.1515/med-2024-0982. eCollection 2024.
3
Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses.
肝细胞癌肝移植与肝切除术的比较:通过荟萃分析的生存荟萃分析促进广泛的合作研究。
Front Oncol. 2024 Mar 18;14:1366607. doi: 10.3389/fonc.2024.1366607. eCollection 2024.
4
Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns.复发性肝细胞癌患者的治疗策略:消融及其联合模式。
J Cancer. 2024 Feb 25;15(8):2193-2205. doi: 10.7150/jca.93885. eCollection 2024.
5
Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.根治性肝切除术后输血对肝癌患者生存影响的阶段性分析——一项回顾性研究。
Langenbecks Arch Surg. 2024 Mar 4;409(1):83. doi: 10.1007/s00423-024-03278-z.
6
Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection.原发性肝癌切除术后基于生物标志物和影像学指标的生存率曲线模型的建立与应用。
Cancer Med. 2023 Jun;12(12):13329-13341. doi: 10.1002/cam4.6031. Epub 2023 May 11.
7
Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence.基于物理的组织模拟器用于建模多细胞系统:肝再生和肝细胞癌复发的研究。
PLoS Comput Biol. 2023 Mar 6;19(3):e1010920. doi: 10.1371/journal.pcbi.1010920. eCollection 2023 Mar.
8
Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment.根治性治疗后早期肝细胞癌初次复发的手术切除与经皮超声引导下射频消融的比较
Cancers (Basel). 2022 Nov 10;14(22):5524. doi: 10.3390/cancers14225524.
9
Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.预测根治性切除术后无大血管侵犯的肝细胞癌早期复发的术前和术后列线图。
BMC Surg. 2022 Jun 17;22(1):233. doi: 10.1186/s12893-022-01682-0.
10
Image-matching digital macro-slide-a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma.图像匹配数字大切片——一种用于检测肝细胞癌微血管侵犯的新型病理检查方法
Hepatol Int. 2022 Apr;16(2):381-395. doi: 10.1007/s12072-022-10307-w. Epub 2022 Mar 16.